Position in AXGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31,956,036
New position
Shares Held
964,565
first reported quarter
Ownership
1.81%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 46.787619289524294.ToString("F0")%
None 53.212380710475706.ToString("F0")%
Position in Medical Devices
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $10,802,033,266 across 28 Medical Devices names. AXGN ranks #12 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
27,070,518 | $2,779,330,079 | |
| 2 | SYK |
Stryker Corp
|
8,121,707 | $2,668,711,698 | |
| 3 | EW |
Edwards Lifesciences Corp
|
22,011,101 | $1,762,648,965 | |
| 4 | BSX |
Boston Scientific Corp
|
18,833,406 | $1,181,796,224 | |
| 5 | MDT |
Medtronic plc
|
7,525,572 | $652,090,810 | |
| 6 | STE |
STERIS plc
|
2,873,365 | $635,387,197 | |
| 7 | DXCM |
Dexcom Inc
|
9,326,240 | $585,687,870 | |
| 8 | INSP |
Inspire Medical Systems, Inc.
|
2,535,954 | $130,804,505 |
All Filings in AXGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,956,036 | 964,565 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||